Nucleofection-Based CRISPR/Cas Delivery in Human T Cells for Immunotherapy Applications

María Ortiz-Bueno, Alejandro Millán-López, Kornel Labun, Karim Benabdellah

Open source

DOI
10.1007/978-1-0716-5547-4_20
Published
2026-09-23
Container
Methods in Molecular Biology
Publisher
Springer US
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/978-1-0716-5547-4_20,
  title = {Nucleofection-Based CRISPR/Cas Delivery in Human T Cells for Immunotherapy Applications},
  author = {María Ortiz-Bueno and Alejandro Millán-López and Kornel Labun and Karim Benabdellah},
  year = {2026},
  journal = {Methods in Molecular Biology},
  doi = {10.1007/978-1-0716-5547-4_20},
  url = {https://doi.org/10.1007/978-1-0716-5547-4_20}
}

RIS

TY  - JOUR
TI  - Nucleofection-Based CRISPR/Cas Delivery in Human T Cells for Immunotherapy Applications
AU  - María Ortiz-Bueno
AU  - Alejandro Millán-López
AU  - Kornel Labun
AU  - Karim Benabdellah
PY  - 2026
JO  - Methods in Molecular Biology
DO  - 10.1007/978-1-0716-5547-4_20
UR  - https://doi.org/10.1007/978-1-0716-5547-4_20
ER  - 

APA

Ortiz-Bueno, M., Millán-López, A., Labun, K., & Benabdellah, K. (2026). Nucleofection-Based CRISPR/Cas Delivery in Human T Cells for Immunotherapy Applications. Methods in Molecular Biology. https://doi.org/10.1007/978-1-0716-5547-4_20

Source records